Results for the "Technology Intensified Diabetes Education Study in African Americans" for Type 2 Diabetes were posted on 2026-03-06. The study enrolled 200 participants and reported initial mean Hemoglobin A1c levels for its two groups.
Background
Type 2 Diabetes is a chronic condition affecting millions worldwide. Effective management often involves lifestyle modifications, education, and medication. The "Technology Intensified Diabetes Education Study in African Americans" was designed to test an intervention combining technology with diabetes education and skills training, specifically for African Americans with poorly controlled Type 2 Diabetes. This focus addresses health disparities and aims to improve outcomes in a vulnerable population.
Trial design
This completed study, which did not specify a phase, enrolled 200 participants. The study focused on individuals with Diabetes Mellitus, Type 2, also referred to as Diabetes Mellitus, Adult-Onset, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Noninsulin Dependent, and Diabetes Mellitus, Type II. The trial aimed to test the usefulness of an intervention combining technology with diabetes education and skills training, specifically for African Americans with poorly controlled Type 2 Diabetes. Key measurements were reported for a "Technology Intensified" group and a "Usual Care" group.
Key results
The study reported initial Hemoglobin A1c measurements for both participant groups:
- For the Technology Intensified group, the mean Hemoglobin A1c was 9.8 (Standard Deviation 2.1) mean percent of HbA1c.
- For the Usual Care group, the mean Hemoglobin A1c was 9.6 (Standard Deviation 1.7) mean percent of HbA1c.
What this means
The reported Hemoglobin A1c values represent the initial glycemic control of the study participants at the time of measurement. With mean HbA1c levels of 9.8% and 9.6% for the respective groups, these figures underscore that the study enrolled individuals with poorly controlled Type 2 Diabetes, aligning with the trial's stated purpose. These baseline measurements are crucial for evaluating the effectiveness of the "Technology Intensified Diabetes Education" intervention once post-intervention data becomes available. The current results do not indicate the impact of the intervention but establish the starting point for assessing its potential benefits.
Source
The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for study NCT02088658, titled "Technology Intensified Diabetes Education Study in African Americans", were posted on 2026-03-06 on clinicaltrials.gov.